Categories: News

EssilorLuxottica: First-Quarter 2023 Revenue Conference Call Invitation

FirstQuarter 2023 Revenue
Conference Call Invitation

Mr STEFANO GRASSI, Chief Financial Officer, and
Mr GIORGIO IANNELLA, Head of Investor Relations,
have the pleasure of inviting you to our First-Quarter 2023 Revenue Conference Call on:

Thursday, April 20, 2023, at 6:30 pm CEST

Please note that both the Press Release publication and the Conference Call start have been moved to the evening time, i.e. 6:00 pm CEST for the Press Release and 6:30 pm CEST for the Conference Call.

Dial-in telephone access

If you wish to dial into the conference call, please pre-register at the following link to receive personal credentials (Dial-in numbers, Conference ID and User ID):

https://aiti.capitalaudiohub.com/essilorluxottica/reg.html

If you encounter any issue in the pre-registration phase you may contact ir@essilorluxottica.com, providing your name and surname and the name of your company.

Live webcast

You can watch the presentation at the following link:

https://streamstudio.world-television.com/1217-2090-35663/en

The press release will be published at 6:00 pm CEST on the same day and the presentation slides will be made available prior to the call. Both can be found on https://www.essilorluxottica.com/investors.

Attachment

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

7 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

10 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

10 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

10 hours ago